General Information
Version
6.5
Revision date
2023-04-30
Product name
Estradiol valerate for system suitability
CAS No.
979-32-8
REACH No
is
Emergency telephone
+(34)-931768545
Icons in SDS
Company Information
company name
Merck Life Science S.L
e-mail address of the competent person responsible for the Safety Data Sheet
serviciotecnico@merckgroup.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H351, H361fd, H362, H410
Hazard statements
Code
Statements
H351
Suspected of causing cancer
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Classification
2.2 Label elements
Labelling
Signal word
Warning Warning
Hazard statements
H351 Suspected of causing cancer. H361fd Suspected of damaging fertility. Suspected of damaging the unborn child. H362 May cause harm to breast-fed children. H410 Very toxic to aquatic life with long lasting effects. Reduced Labeling (<= 125 ml) H351 Suspected of causing cancer. H362 May cause harm to breast-fed children. H361fd Suspected of damaging fertility. Suspected of damaging the unborn child.
Precautionary statements
P202 Do not handle until all safety precautions have been read and understood. P260 Do not breathe dusts or mists. P263 Avoid contact during pregnancy and while nursing. P264 Wash skin thoroughly after handling. P273 Avoid release to the environment. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P202 Do not handle until all safety precautions have been read and understood. P308 + P313 IF exposed or concerned: Get medical advice/ attention.
Supplemental label elements
none none
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher. Caution: Physiologically highly active, therapeutically usable substance. The substance must be handled with the care required for hazardous materials.
